Obesity at diagnosis is associated with inferior outcomes in hormone receptor-positive operable breast cancer. - Test2 - elhamkhani - TriplyDB

Obesity at diagnosis is associated with inferior outcomes in hormone receptor-positive operable breast cancer.

Obesity at diagnosis is associated with inferior outcomes in hormone receptor-positive operable breast cancer.

http://www.wikidata.org/entity/Q36650415

about

Obesity and cancer: mechanistic insights from transdisciplinary studies Lifestyle Factors in Cancer Survivorship: Where We Are and Where We Are Headed Body mass index and survival in women with breast cancer-systematic literature review and meta-analysis of 82 follow-up studies Body Mass Index with Tumor 18F-FDG Uptake Improves Risk Stratification in Patients with Breast Cancer The influence of obesity on survival in early, high-risk breast cancer: results from the randomized SUCCESS A trial Body mass index, diabetes, and triple-negative breast cancer prognosis.Association of obesity and circulating adipose stromal cells among breast cancer survivors.Body mass index and weight change in relation to triple-negative breast cancer survival.Impact of underweight after treatment on prognosis of advanced-stage ovarian cancer.Impact of obesity on development and progression of mammary tumors in preclinical models of breast cancer Estrogen receptor (ER)α-regulated lipocalin 2 expression in adipose tissue links obesity with breast cancer progression Aggressive estrogen-receptor-positive breast cancer arising in patients with elevated body mass index.Breast cancer survivorship: a comprehensive review of long-term medical issues and lifestyle recommendations.Increased expression of tumor proliferation genes in Hispanic women with early-stage breast cancer Cell-Based High-Throughput Screening for Aromatase Inhibitors in the Tox21 10K Library Increased serum tumor necrosis factor receptor-associated factor-6 expression in patients with non-metastatic triple-negative breast cancer.Relationship between body mass index and the expression of hormone receptors or human epidermal growth factor receptor 2 with respect to breast cancer survival.Long-Term Follow-Up of the E1199 Phase III Trial Evaluating the Role of Taxane and Schedule in Operable Breast Cancer.Relationship between body mass index and incidence of breast cancer Weight Loss and Mortality in Overweight and Obese Cancer Survivors: A Systematic Review Racial and ethnic disparities in the impact of obesity on breast cancer risk and survival: a global perspective.Current nutrition promotion, beliefs and barriers among cancer nurses in Australia and New Zealand Body Mass Index at Diagnosis and Breast Cancer Survival Prognosis in Clinical Trial Populations from NRG Oncology/NSABP B-30, B-31, B-34, and B-38.Predictive factors of head and neck squamous cell carcinoma patient tolerance to high-dose cisplatin in concurrent chemoradiotherapy.Overweight and obesity predict better overall survival rates in cancer patients with distant metastases.Impact of central obesity on prognostic outcome of triple negative breast cancer in Chinese women Breast cancer in women using digoxin: tumor characteristics and relapse risk Effect of body mass index on tumor characteristics and disease-free survival in patients from the HER2-positive adjuvant trastuzumab trial N9831.Local adipocytes enable estrogen-dependent breast cancer growth: Role of leptin and aromatase.Body mass index and its association with clinical outcomes for advanced non-small-cell lung cancer patients enrolled on Eastern Cooperative Oncology Group clinical trials.Obesity, diabetes, and survival outcomes in a large cohort of early-stage breast cancer patients.Aryl hydrocarbon receptor ligands inhibit igf-ii and adipokine stimulated breast cancer cell proliferation Post-diagnosis adiposity and survival among breast cancer patients: influence of breast cancer subtype.Bigger is not better! The risk of obesity and risk of breast cancer incidence and recurrence in the Indian subcontinent.The association between adiposity and breast cancer recurrence and survival: A review of the recent literature Body mass index and circulating oestrone sulphate in women treated with adjuvant letrozole.Obesity and survival in operable breast cancer patients treated with adjuvant anthracyclines and taxanes according to pathological subtypes: a pooled analysis The obesity-inflammation-eicosanoid axis in breast cancer.Clinical studies examining the impact of obesity on breast cancer risk and prognosis.How do I follow patients with early breast cancer after completing adjuvant therapy.

P2860

Q26786829-A8B62D43-E675-4719-9480-AE546B63A688 Q27011454-0DB0BA8D-6B9E-4BDC-A3F8-42E1E98EDF0A Q27014939-8174AC83-B8F9-42AA-9FE5-7D06286B0B67 Q28109681-054B7CB3-6CD4-4783-8238-A97EF758E68B Q28389045-709CF4BE-A207-420B-8E21-51AD85771341 Q30458239-7AE36A40-E529-4E0F-8E33-C889377BCE79 Q33591042-3B9AC2CA-4CC2-4E58-A72F-DC1F59CBBE72 Q33712501-96945085-C029-44D3-AEC2-94D45A396923 Q33890809-E6F51268-F8C0-43F3-B614-881383B3BB06 Q34975962-4BB3EA72-1CA7-4622-B8D6-37BC36B3AA9C Q35126653-CAF84788-71D2-47BF-9186-07B133675C50 Q35186057-D17C6FCA-FB82-466B-AB2F-01C10262921A Q35490056-E0E49F27-0CEF-4FDD-B915-394BE0173851 Q35596953-03751974-84F8-4301-BFAF-7F1A58D2EF93 Q35682481-03BB645D-58E6-4D79-BD53-2ED09CE1EC7F Q35759017-DC3E5277-5383-41D8-9941-3705A4B9C937 Q35834893-F5D24925-2435-4A77-ADEA-8E65E36E1BEE Q35847450-4A3C5100-CDBB-49EE-BCB6-BE88D0B21859 Q36046830-FE17605A-4746-4BDA-9B7E-946A064AFA7E Q36242901-D0FF0969-0EBF-4C1A-9B4B-6B12AE895A38 Q36273231-997DB5E1-349D-454D-BA0E-F6028BCFFDB1 Q36286887-10F716DB-8CF4-4BEC-A8A3-7797FD7B732C Q36463767-AF014739-DF05-45D1-BE0E-AEBB23615891 Q36524522-97B150B8-BECF-4DD1-B381-D01CB8D301AE Q36797278-357A48E9-D5DB-427F-B9AB-3E4C74504D38 Q36894869-09BC165E-BCB0-4F00-A0F8-AF4D2D06731B Q36903225-93651560-1783-40CD-BD6C-14C46A923029 Q36941405-21BCB98A-8CED-4C82-83A3-FF0E9AC54AFC Q37129102-C642C233-EA1D-4D44-A5F0-1F4074EA58DD Q37149246-F624307A-7AE0-4C4F-A6F6-398989EE942E Q37200502-685BDA66-BBEE-4A37-960D-5CE136F41DAF Q37221957-3572577E-A004-448C-8DEE-19735DDBA854 Q37326372-7118B1F0-D6D8-43B0-B0FC-05731B71D635 Q37481690-1734BAC7-705C-4632-B87D-A81E9A5608CE Q37579337-55DC29C4-19AB-4EB2-B7EC-32BD6A8872DE Q37632155-4E522C34-56DA-407B-80C8-E7ABC8F474DD Q37690278-D29DC6AD-029E-4463-9CEF-75D07A95F17E Q38156366-E01528C6-22F6-4A78-999C-7ADA4EE35145 Q38162118-C8B53C29-E131-48DB-B064-227C6570DAD0 Q38172001-C3E55130-366A-4B1B-86B4-5E3C0EC2E5DF

P2860

Obesity at diagnosis is associated with inferior outcomes in hormone receptor-positive operable breast cancer.

http://www.wikidata.org/entity/Q36650415

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Obesity at diagnosis is associ ...... sitive operable breast cancer.

@ast

Obesity at diagnosis is associ ...... sitive operable breast cancer.

@en

type

label

Obesity at diagnosis is associ ...... sitive operable breast cancer.

@ast

Obesity at diagnosis is associ ...... sitive operable breast cancer.

@en

prefLabel

Obesity at diagnosis is associ ...... sitive operable breast cancer.

@ast

Obesity at diagnosis is associ ...... sitive operable breast cancer.

@en

P1433

Q36650415-AA7799B3-591F-4450-AC9B-E1994C3EC17D

P1476

Q36650415-329E97C6-4771-4D5D-959E-E2B8339BCD78

P2093

Q36650415-152CCEF7-5B32-4FB0-BBDF-474BA6DA19E0

Q36650415-174CB6E8-884A-44A2-964C-CE9AC73FAACA

Q36650415-260C0188-1786-4EF6-A4B2-03CD8C793A43

Q36650415-4318B5E9-E588-4207-92E3-7FADEC8FA1E3

Q36650415-4B83EDA7-940C-48EA-87F4-E9A5C0E8A1A1

Q36650415-72259B86-35BE-4234-9B96-122AA3118246

Q36650415-7B2E30CE-5317-4F77-8D87-006AC04A7F35

Q36650415-8EF04271-011A-492D-A89B-22813AB23083

Q36650415-C31EAA4F-EDE9-4084-BBC9-2EE44F8884C1

Q36650415-CF78C2DC-5174-4A13-904A-78D8EBCF2727

P2860

Q36650415-004029A5-DE29-43EB-B40D-6B688CC790F3

Q36650415-14FDB8CC-2C19-40C7-A05F-751DF0EFC680

Q36650415-1F48E1E0-B7D3-4056-AD18-8E0BBF8EB425

Q36650415-259F7B36-53AE-4594-9E67-58450EF78A56

Q36650415-25AC3856-EC02-4D39-BF77-D2E582A8E902

Q36650415-2B21BAE0-F015-4AED-B677-881775BD77B9

Q36650415-41B8F1DB-A28A-4250-9DBA-BF0B33218C1F

Q36650415-434BF992-C1F1-4C20-B993-FE064F7209A4

Q36650415-4415EB6D-2CAB-4C84-AA4D-7591A1354327

Q36650415-4515B5FE-BC21-4EBC-B75C-11229FBC4630

P304

Q36650415-C91CD0C7-6745-4D9F-BA49-C0C7B5D15515

P31

Q36650415-44E8B4FA-D6C5-4B5A-AA62-8A85BB152685

P356

Q36650415-448035E1-4D69-4185-ABB2-E81C9EF6CE54

P407

Q36650415-1D310F4B-BB5F-44AC-BD9A-45289D64F3B9

P433

Q36650415-AE27EC8D-B39F-4B6E-A1F5-0CF557E3C9B8

P478

Q36650415-7E18DF50-3E1B-4495-A597-64ACDEF246D8

P50

Q36650415-24CD0D3D-A91D-4CBC-977F-497AA6C1C3B2

P577

Q36650415-A6D66A4F-B539-47C0-BC39-00079759DB97

P698

Q36650415-5CFA234B-C2F7-4F17-BFC3-0511167CAE39

P921

Q36650415-EEBDD126-914A-475F-B569-6571A76AE427

P932

Q36650415-97784214-9456-4877-9556-8FB5C266C6A6

P356

P1433

P1476

Obesity at diagnosis is associ ...... sitive operable breast cancer.

@en

P2093

Antonio C Wolff

http://www.w3.org/2001/XMLSchema#string

Edith A Perez

http://www.w3.org/2001/XMLSchema#string

Fengmin Zhao

http://www.w3.org/2001/XMLSchema#string

George W Sledge

http://www.w3.org/2001/XMLSchema#string

Jennifer A Ligibel

http://www.w3.org/2001/XMLSchema#string

John Fetting

http://www.w3.org/2001/XMLSchema#string

Joseph A Sparano

http://www.w3.org/2001/XMLSchema#string

Molin Wang

http://www.w3.org/2001/XMLSchema#string

Nancy E Davidson

http://www.w3.org/2001/XMLSchema#string

Silvana Martino

http://www.w3.org/2001/XMLSchema#string

P2860

Influence of a diet very high in vegetables, fruit, and fiber and low in fat on prognosis following treatment for breast cancer: the Women's Healthy Eating and Living (WHEL) randomized trial

Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer.

Global cancer statistics, 2002

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

Repeated observation of breast tumor subtypes in independent gene expression data sets

Dietary fat reduction and breast cancer outcome: interim efficacy results from the Women's Intervention Nutrition Study

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

Cancer statistics, 2009

Prevalence and trends in obesity among US adults, 1999-2008

Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies

P304

5937-5946

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CNCR.27527

http://www.w3.org/2001/XMLSchema#string

P407

P433

23

http://www.w3.org/2001/XMLSchema#string

P478

118

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-08-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22926690

http://www.w3.org/2001/XMLSchema#string

P921

P932

3586227

http://www.w3.org/2001/XMLSchema#string